El-Samadony, Hesham http://orcid.org/0000-0003-2067-7927
Azzazy, Hassan M. E.
Tageldin, Mohamed Awad
Ashour, Mahmoud E.
Deraz, Ibrahim M.
Elmaghraby, Tarek
Funding for this research was provided by:
ACDIMA, Egypt (NA)
Article History
Received: 18 August 2018
Accepted: 30 December 2018
First Online: 4 January 2019
Compliance with Ethical Standards
:
: HMEA is a co-founder of D-Kimia, LLC, a novel diagnostic solutions company and author of patents on use of gold nanoparticles for detection of infectious agents. Other authors declare no competing interest.
: The Research Ethics Committee of the Egyptian Ministry of Health approved study protocol (Approval No. 31-2014/8).
: A written informed consent was obtained from all enrolled patients.